Knowles Corporation (KN) Q3 2025 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call highlights strong revenue growth, improved gross margins, and strategic expansion in specialty films, with optimistic guidance for MedTech and Precision Devices. While there are some uncertainties in M&A timelines and industrial segment growth, the overall sentiment remains positive due to high demand, operational improvements, and robust bookings. The Q&A session reinforced confidence in future growth and margin improvements, leading to a positive outlook for stock price movement.
Key Financial Performance
Revenue $153 million, up 7% year-over-year. The increase is attributed to the company's focus on markets and products with significant competitive advantages.
Earnings Per Share (EPS) $0.33, up 22% year-over-year. This growth reflects strong operational performance and demand for the company's products.
Cash from Operations $29 million, above the midpoint of the guided range. This was driven by lower-than-expected net working capital.
Medtech & Specialty Audio Revenue $65 million, up 2% year-over-year. Growth was driven by increased demand in the specialty audio market.
Precision Devices Revenue $88 million, up 12% year-over-year. Growth was driven by increased demand across all end markets, including medtech, defense, industrial, and EV and energy.
Gross Margins (Medtech & Specialty Audio) 53%, flat year-over-year but improved more than 200 basis points sequentially. This reflects operational improvements.
Gross Margins (Precision Devices) 41.5%, up 150 basis points year-over-year. Improvements were due to higher demand and production volumes in ceramic capacitors and RF microwave product lines, partially offset by higher production costs and lower yields in the specialty film product line.
R&D Expense $9 million, flat year-over-year.
SG&A Expense $26 million, up $2 million year-over-year. The increase was driven by annual merit increases and higher incentive compensation costs.
Interest Expense $2 million, down $2 million year-over-year. This reduction reflects the company's efforts to reduce debt levels.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
Medtech & Specialty Audio: Revenue was $65 million, up 2% year-over-year. Growth driven by new product adoption and cutting-edge technology. Gross margins expected to remain above 50% for 2025.
Precision Devices: Revenue was $88 million, up 12% year-over-year. Growth driven by design wins and robust trends in medtech, defense, industrial, EV, and energy markets. Specialty film production ramp-up showing positive trends.
Defense Market: Strong growth with design wins and bookings outpacing other markets. Products like RF filters and capacitors are in high demand for military applications, supported by increased defense spending on electronic warfare.
Specialty Film Expansion: Investments in specialty film production capacity are expected to support future growth.
Revenue Growth: Total revenue for Q3 2025 was $153 million, up 7% year-over-year. EPS grew by 22% year-over-year to $0.33. Cash from operations was $29 million.
Operational Efficiency: Improved factory capacity utilization in ceramic capacitors and RF microwave product lines. Sequential improvement in specialty film production output and gross margins.
Organic Growth Strategy: Focus on leveraging unique technologies and creating custom products for markets with strong secular growth trends. Expected organic growth rates at the high end of 4%-6% range for 2025.
Financial Strategy: Repurchased $20 million in shares and reduced bank borrowings by $15 million. Strong balance sheet with liquidity over $350 million to support growth and acquisitions.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Specialty Film Product Line Ramp-Up: Higher production costs and lower-than-expected yields during the ramp-up of the specialty film product line have impacted gross margins. While trends are improving, this remains a challenge.
Tariff Exposure: Exposure to tariffs is less than 5% of revenue and 3% of cost of goods sold. The company has managed to pass these costs to customers, but the situation remains fluid and could pose risks.
Debt Management: The company has $176 million in debt, including a seller note maturing soon. While manageable, this requires careful cash flow management to avoid financial strain.
Increased SG&A Expenses: Selling, general, and administrative expenses increased by $2 million year-over-year, driven by merit increases and higher incentive compensation costs, which could pressure margins.
Tax Rate Increase in 2026: The effective tax rate is expected to increase significantly from 7%-11% in 2025 to 15%-19% in 2026, which could impact net earnings.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Medtech & Specialty Audio Revenue Growth: Expected revenue growth within the range of 2% to 4% for the year 2025, supported by operational excellence and new product adoption.
Precision Devices Segment Growth: Anticipated revenue growth at the high end of the 6% to 8% range in 2025, driven by strong demand in defense, industrial, EV, and energy markets, as well as robust secular trends.
Defense Market Performance: Defense spending is increasing, with a focus on electronic warfare, benefiting the company's RF filters and capacitors used in military applications. Design wins and bookings in this market are strong.
Organic Growth Projections: The company expects organic growth rates at the high end of the 4% to 6% range for 2025, supported by new design wins, a healthy backlog, and secular growth trends.
Specialty Film Production Expansion: Expansion of specialty film production is expected to contribute to growth in 2025 and beyond.
Q4 2025 Revenue and EPS Guidance: Revenues projected between $151 million and $161 million, up 9% year-over-year at the midpoint. EPS expected to range from $0.33 to $0.37 per share.
Q4 2025 Cash Flow and Capital Spending: Cash generated by operating activities projected to be $30 million to $40 million. Capital spending expected to be $12 million, with full-year capital spending at approximately 5% of revenues.
Tax Rate Outlook: Effective tax rate expected to increase to 15% to 19% in 2026, up from 7% to 11% in Q4 2025.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
Share Repurchase: Cash generation from operations continued to be robust in the third quarter, allowing Knowles to purchase $20 million in shares and reduce outstanding bank borrowings by $15 million. During the third quarter, we purchased 940,000 shares at a total cost of $20 million.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:What are the current capacity and future plans for specialty film, and how does the company see revenue growth into next year?
A:The company expects the energy order received in Q1 to start delivery in Q2, ramping fully by the end of Q2, contributing around $25 million. The specialty film business backlog, excluding the energy order, is close to $30 million. The specialty film line is projected to generate $25-$30 million this year, and with the energy order, it should reach $55-$60 million next year. Capacity is being expanded to meet these demands.
Q:What underpins the high end of the target growth range for Medtech, Precision Devices, or any subsegment?
A:Medtech & Specialty Audio is expected to grow 2%-4% next year, while Precision Devices is projected to grow at the high end or slightly above the 6%-8% organic growth range. Growth is driven by design win activity across med, industrial, defense, and EV markets, leveraging unique technologies customized for specific applications.
Q:Can you elaborate on the products and follow-on orders for specialty film in non-energy applications?
A:Specialty film focuses on pulse power applications, such as defibrillators, railgun applications, and radiotherapy. Emerging applications include downhole applications for fracking and drill bit cleaning, currently in the prototype phase. The company is in a unique position with U.S.-based manufacturing and technology capabilities.
Q:What is the update on the M&A environment and the company's approach to acquisitions?
A:The company is focused on disciplined acquisitions that clearly add value. The M&A environment has improved with more assets available and lower interest rate expectations. The company is hopeful to complete an acquisition in the next 1-2 years but remains selective.
Q:What is the current book-to-bill ratio, and how has it changed from the previous quarter?
A:The book-to-bill ratio for Precision Devices was 1 for the quarter, with the second-largest order quarter in the last 4 quarters. Bookings remain strong, particularly in defense and with distribution partners, and the backlog is high.
Q:How are palladium price increases impacting gross margins, and what measures are in place to mitigate this?
A:Palladium costs have increased, but the company has prebuys in place through the first half of next year at prices below the current market. If prices remain high, discussions with customers may occur. Gross margins are not expected to be negatively impacted in the short term.
Q:What is the gross margin impact from the ramp in specialty film, and how will it evolve?
A:Specialty film gross margins are currently below the company average due to added costs and higher scrap rates. Sequential improvement is expected in Q4, Q1, and Q2, with a significant improvement in Q3 when the energy order fully ramps.
Q:What is the gross margin leverage on incremental utilization rates, and where are utilization rates currently?
A:Gross margin leverage on incremental revenue is 35%-40% on average, varying by product line. Utilization rates differ across product lines, with some running close to full capacity.
Q:What is the exposure to distribution and industrial within Precision Devices, and have inventory levels normalized?
A:Distribution and industrial exposure within Precision Devices is around 40%. Inventory levels have normalized, and ordering trends align with demand. The distribution business is experiencing growth, particularly in industrial segments.
Q:Review of Unclear Management Responses
A:Management avoided providing specific details on the exact growth rates for industrial segments within distribution, citing opacity due to inventory burn-down effects. Additionally, they did not provide a clear timeline for completing an acquisition, only expressing hope for the next 1-2 years.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
Audio excellence
Audio opportunity
Cash generation
Day Precision
Defense spending
EV energy
Knowles Conference
Knowles duty
Knowles share
Knowles statement
Medtech Specialty
RF microwave
Specialty Audio
ability end
adoption cutting
advantage dividend
application design
application munition
application radar
bank borrowing
base application
basis call
booking end
borrowing balance
call design
capacitor RF
capacitor energy
cash midpoint
channel inventory
combination date
communication capacitor
custom product
intimacy
market solution
scale market
segment end
solution result
technology custom
trend end
KN Transcript
Knowles Corporation (KN) Q4 2025 Earnings Call Transcript
Positive2-5
Despite some concerns about management's lack of clarity on gross margin guidance, the overall sentiment is positive. The company reported strong financial performance, with significant revenue growth in key segments and optimistic guidance for 2025. The Q&A session highlighted promising organic growth opportunities and strong demand across various markets. The company's strategic initiatives and operational efficiencies are expected to drive further growth, supporting a positive stock price movement in the short term.
Knowles Corporation (KN) Q3 2025 Earnings Call Transcript
Positive10-23
The earnings call highlights strong revenue growth, improved gross margins, and strategic expansion in specialty films, with optimistic guidance for MedTech and Precision Devices. While there are some uncertainties in M&A timelines and industrial segment growth, the overall sentiment remains positive due to high demand, operational improvements, and robust bookings. The Q&A session reinforced confidence in future growth and margin improvements, leading to a positive outlook for stock price movement.
Knowles Corporation (KN) Q2 2025 Earnings Call Transcript
Positive7-24
The company reported strong financial performance with an 8% revenue increase and a 20% EPS rise. While SG&A expenses increased, the company maintained manageable debt levels and reduced interest expenses. Share repurchases of $30 million reflect confidence in cash flow. Positive guidance and strong bookings further support a positive outlook. Despite some margin pressures, the overall sentiment is positive, especially with expected margin improvements and continued revenue growth.
Knowles Corporation (NYSE:KN) Q1 2025 Earnings Call Transcript
Positive4-26
The earnings call reveals a mixed but generally positive outlook. Financial performance is stable with strong cash flow and debt reduction, despite slight revenue decline and margin pressure. Optimistic guidance for Q2 and beyond, along with strategic customer commitments, suggests future growth. Share repurchase and debt reduction enhance shareholder value. The Q&A indicates potential market share gains and improved margins. Tariff impacts are minimal, and customer demand remains solid. Overall, these factors suggest a potential positive stock price movement over the next two weeks.
KN Slides
KN Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
